Rebels Edge · Tue, Jul 21, 2026

What’s Breaking the Market Right Now (Hint: It’s Not Stocks)

Summary

The hosts attributed market weakness and elevated volatility primarily to rising crude oil prices amid conflict in the Middle East. Jeff Garbacz reviewed record short-interest share counts and sector positioning, while the hosts discussed AppLovin, Wave, and Miller Knoll, expressing interest in Wave but caution toward Miller Knoll.

WTI crude traded around $94, with volatility near 27; the hosts identified oil as the main driver of choppy equity markets.
NYSE and Nasdaq short-interest share counts reached record highs, while aggregate short-position value declined to approximately $1.695 trillion.
Software short-position value fell over three months, prompting Garbacz to flag semiconductors as a potential area for increased short positioning.
Energy short-position value rose from about $82.75 billion to $95.77 billion over two weeks despite rising oil prices; longer-dated crude futures traded substantially below near-term contracts.
Garbacz highlighted increased short positioning in Banco Santander as a potential short-squeeze setup.
AppLovin fell more than 8%, with discussion focused on valuation, potential competition from Meta, short sellers, and insider selling.
The hosts expressed interest in Wave near its lows, with John considering a call spread allowing two or three months.
Miller Knoll fell more than 20% following earnings and revenue misses, weaker margins, and a soft outlook; both hosts declined to buy despite order growth.

NVDA SAN CBOE APP META WVE MLKN

Full transcript

Welcome back to the Rebel's Edge. Pete Najarian and I will be breaking down exactly what is breaking down or breaking to the upside. And here's a hint, what's breaking to the upside is why the market's breaking down. And we've got Jeff Garbacz joining us about the short report and some new tweaks
he's made to that. All on today's Rebel's Edge.
>> [music] [music] >> All right, the last one of this week. We are Monday through Thursday, everybody knows that by now, but
gives us travel time on Friday. So that that's kind of nice. But uh pretty interesting, John, these markets each and every day. I I just was listening to the president back there as well. Um just talking about what's going on and the progress and this, that, and the other. But um there's still plenty of volatility in
this market, isn't there?
Yeah. Um it takes a while to exhaust what at least 20 years worth of missile building and all the rest. I mean, I think as far as their navy, it's at the bottom of the sea. That was the funny one, Pete, when um Hegseth said, "We've negotiated with Iran and we've decided we'll take the
top and they've got the bottom of the sea." >> [laughter] >> I got to tell you that guy is super intelligent. He's the real deal and he is in the best position for who he is, I think, in government. I mean, he's he is a classic. And he's a Minnesotan, so I got to love the guy. Forest Lake, right?
Right there. About 5 mi that way up.
>> [laughter] >> Well, uh so because crude oil is uh what's moving the markets all the time, folks.
The fact that crude went back up to about 93, that's West Texas Intermediate. Um what was it? Beat 6% today or something like that? Four to six, somewhere in that range. Um that's the macro. And the macro is that when uh
people hear that uh Trump rejected uh and as well as the UAE, Pete, United Arab Emirates also said, "Nope. We're not stopping. We're going for these guys. They keep shooting rockets at us.
Screw them. Until they're all done with their rockets and missiles, we're not stopping." So, that of course boosted volatility a little bit. So, that's your handle, Pete. What do you got for volatility?
>> Well, you know, it's as you know, John, and everybody knows now because I think they are starting to focus a little bit more on it. But I mean, the choppy uh markets that we've got right now is obviously the price of oil and the reaction with volatility, right? And volatility we've been as low as 21 in this last month. I'm just looking at the month of March and how things have sort
of played out. But we're mostly, John, somewhere between call it 24, 27, in that range. And a lot of that has to do with everything you just talked about. I mean, West Texas, I mean, I'm looking at it with the high today just under 95. I think it hit 94.80.
Um that's not good because obviously when we start seeing oil get back to those kind of levels, that's when people start getting nervous. We actually had the Dow get all the way back into the green after it started off today in pretty deep red, down 350, something like that.
Um and now it's pulled back again because of the fact that here we are. We find ourselves, like you were just saying, 5 or 6%, whatever it is, but uh you know, somewhere just north of 94, 94 and a quarter, something close to that.
So, yeah, that that is the issue right now and that's why volatility is where it is, which is pushing a little bit closer and a little bit closer. And here it is at 27.
Well, um let's do a a quick hit with prediction markets, Pete, and then bring in Jeff Garbacz.
Let's do it.
Prediction Prediction markets, I'm going to say SpaceX IPO by the end of March?
Nope, because they haven't filed anything yet. Um they're expected and the way it works, folks, is they have to file with the exchange. Uh I believe it will be the New York Stock Exchange, but I do not know that for a fact. Um but then they have to, you know, that S-1 gets filed and so forth. And then they
come out with uh what the terms are and so forth, the final terms. And they don't price it obviously until the day before. But uh as you can see on the screen, the odds say by the end of June. And why do we think they're going to file it in April and then perhaps come out in June, Pete?
Because Elon Musk really likes that joke about 420. Which it tends to be a cannabis joke. But nonetheless, he likes 420 as a number, if you will. And uh his birthday's in June. So, that's why a bunch of us that are uh watching this
and in some of the uh early SpaceX uh offerings are thinking, "Yeah, probably June." What do you think, Pete?
Yeah, it makes sense to me, John. I mean, this is a process and the process sometimes got has a snag here, snag there, and it takes a little while. And you and I both are are privy to some of that information because we've had companies that we have had to wait long periods of time before they actually filed and got themselves on the the
ability to actually be a publicly traded stock. So, sometimes those things just take take time. And I think in this case, this is if the numbers are even close to what everybody is saying, this will be an absolute monster. So, I think they're going to want to make sure everything is done and the the I's have the dots and
the T's got the cross and everything else. So, should be pretty interesting as as we get a little bit closer. But I think that June number and the volume there is outrageously bigger than everywhere else. So, it makes a lot of sense. Be aware of this, Rebel's Edge Official is our new home on YouTube. So,
go to Rebel's Edge Official, sign up, hit subscribe, and then click that bell up on top, upper left.
It's upper right.
All right, I'll do it again. Hey, folks, thanks for joining us. And we wanted to tell all of you who watch on YouTube that Rebel's Edge Official is our new home on YouTube. That's Rebel's Edge Official. Hit that, subscribe, and then click in the upper right that bell so
that you get alerted every time there's a new show. Well, let's bring in Jeff Garbacz from the short report, Pete. And from the early morning uh uh predictive stuff that he does uh in the early morning hours. Jeff, welcome, sir.
Thanks a lot. Thanks for having me again. Welcome. We got some more short numbers. And we've got a cool new addition to normally how we look at short interest. So, we'll kind of kind of walk through that a little Sure.
Thanks to a little AI stuff that we're doing. So, let's take a look here at the um latest report in Rebel Squeeze Play Pro, where we updated the short interest that came in from February through the middle of of March.
Um First thing's first, uh uh Nasdaq and New York now have both hit all-time new highs in short interest. I'm going to go down and show this chart right here. You can see we New York had yet to take out the '08
high, but we've now just done it on the latest short interest numbers. And if we go back up here, we're we're approaching um about 20 billion shares that are
short on both NYSE and Nasdaq. And if we go I I kind of did some additional data scraping on stuff. But look at where we've come since 2020.
We were at at 12.9 billion shares short at the end of 2020.
And Nasdaq was at 9.9.
And now we're both almost right at 20 20 billion shares short. Um And what's cool about this is we have down here now quantified
dollars in terms of short positions. So, the overall short interest is at 1.695 trillion dollars from 1.726 trillion. So, we dropped a little bit this last month, even though the
absolute number of shares went up.
What's interesting is software is at 276 from 285.
Semiconductors are 148 from 151.
Interesting thing about semiconductors is that um 45 billion of it was just in Nvidia.
So, that means we only have 100 billion to short everything else. And pharma dropped down to 139 from from 146.
And we're going to look at a uh a chart we've created in what we call our uh our sandbox here.
And this lets us look at like by sector, how much is short, where we were 2 weeks ago in the last update, a month ago, 3 months ago, 6 months ago. So, you can see Well, the interesting thing here about software, which is down here, 3 months ago we were at 321 billion. Now
we're at 276. So, we've dropped about 45 billion. So, to me, a natural question is where are they going to go next? And a lot of the people that will short software are hedge funds that might have an emphasis in technology. So, to me, a natural place to watch is
semiconductors. They're up from 6 months ago, 127 to 147. So, they're up 20 billion. And we know, like I said, that the 45 billion of it was just in Nvidia.
There are a lot of stocks that don't have big short positions right now in semis. So, that's something that we're going to be watching to see. The other area, which is really interesting, um energy.
In the last 2 weeks, it's gone from 82.75 billion shares um in dollars that are short to 95.77 billion shares short. So, an increase of almost 15 billion shares.
And kind of interesting, like, why would they be adding to positions when we're in the middle of a war in the Middle East and the price of oil is is going up?
The uh the The only conclusion that I can come to in looking at the data is if we look at the uh the West Texas crude futures. Here's a chart, you guys. So, what's interesting is look at look at like what the predictions are for May, $91.
But by September, we're at $80. And by January, we're down at $75.
So, it's going to be really interesting to see what happens with this betting on the short side in uh in energy.
And and speaking of bets, in our top 10 bets, look at look at Banco Santander here, John, kind of near you a little bit. Look how they've added the last couple of time periods. Th- This is in the top 10 names.
Um and it was there 2 weeks ago, also.
So, a big bet against Banco Santander.
Um could create a squeeze. Right now, it's kind of going going sideways, but it's interesting to see people betting there. And then the other big bet that's being made is look at look at this Canadian National Resources, which is a rail play um
and gas play, too. It's been going up the last couple time periods, as well, where it's been straight up. So, two kind of interesting plays that we'll be watching to do as potential Rebel Squeeze Play Pro or Elite Ideas. And that is it for right now.
That great stuff, Jeff. Great stuff, Jeff.
As always, great stuff by Jeff Garbutt, folks.
Rebel Squeeze Play Pro and uh the Rebel Squeeze Play. He does both. And uh uh Pete, what he just described was backwardation.
Um backwardation, folks, is where the future price is here, which, as Pete said, is a little over $94 right now for the near-term future. And as Jeff described, the further out you go, the lower it goes, all the way down to whatever, 74, I think he said, or whatever, Pete, out in uh the fall. So,
what would you do, folks, if you had a commodity or if you had candy bars? If you had um a hot jean from uh Sydney Sweeney or whatever, and it was pricing such that you said, "Well, they're paying up right now, but as we go out in
time, it kind of dies down." What would you do? You'd bring AS MUCH AS POSSIBLE TO THE MARKET AT THE higher prices is what you'd do. It's the exact opposite uh of what happens. Backwardation is the exact opposite of what happens when it's low in the front and higher in the back.
If it's low in the front, you buy it, you might put it in storage, and you sell the higher out futures. Yep. That's That's how a normal curve. But backwardation is not normal. No. And we know why. It's not like it's a big secret. Yeah. All right. Uh great stuff
by Jeff Garbutt. Thank you.
>> always. Um Pete, let's just uh let everybody know again about Cboe Global Markets, who is hosting uh an event with us. We are doing it together in Chicago the 23rd and 24th of uh April. Mhm. And I think you guys that
always wanted to see what a trading floor is like and you're anywhere near Chicago should register now. Yeah. And all you have to do is uh pick up the phone and call uh to speak to one of your helpful uh Market Rebellion sales people, like Mel or Brady or a host of
others uh that'd be happy to take your call right now and sign you up. Because they've got great pricing for that. You could come. They've even got great uh rates at a couple hotels nearby. And there's nothing, Pete, really like being in the same room with our customers or
you guys being in the same room with us and being able to look us in the eye and ask us questions, see how we're trading that particular day and so forth, and ask any of the pertinent questions that either have been inhibiting your uh progress as a trader or perhaps even that uh you've seen a breakthrough in
something and you'd like to share it with us. We'd love to hear it. And I don't mean a secret thing. I just mean like all of a sudden you said, "The light came on and I figured out how to do this." And, you know, I was watching Pete on his covered calls, and all of a sudden I decided, "Well, sh- What if I just sold puts? Isn't that the same thing?"
>> [laughter] >> So, anyway, uh by all means, folks, you should pick up the phone, dial uh uh that number on your screen, and you could be sitting there in the classroom or virtually, whichever you prefer. Yep. All right, Pete. We're going to dive right into stocks. Let's
do it. That AppLovin is a stock that we talk about a lot, APP. And some people are saying, "Well, you know, this one's really kind of overvalued." Okay. I mean, that's what makes a market. Some love it, some hate it. Well, short sellers are, just as Jeff was
describing, they've kind of picked on this one lately, Pete. And shares are down another 8% or more today. They're an AI-powered advertising platform, AppLovin is. And uh I think a lot of people uh like that and think that, "Boy, if you get rid of a whole bunch of
uh bodies, you might be able to make a lot more money drop to the bottom line." Uh and yet other people are saying, "Yeah, but look at the multiple." What do you say, Pete? Yeah, I look at AppLovin, John, and um they do have competition out there. Not, you know, they're they're still sitting there uh I think at the top, but I think they're going to have some competition.
Meta's one of the the folks out there that people have uh said there might be concerns about that. But this insider and short sellers and all the rest of it um is pretty interesting. When you start seeing the insiders sell, John, and you have had over 20 different transactions recently of insider selling, um that's pretty amazing. I mean, just
the month of March, I was just taking a look at earlier today. The director selling a lot, the CEO selling a lot, the CTO sold a bunch of shares. And now, are they doing that for any reasons? Are they negative on the stock? We don't know the answer to that. They could be.
Or they just want to take some money out, right? So, I mean, it's It is a position that they're in right now. And when they when people start seeing that, when you and I start seeing insider selling, that tends to push us back just a little bit and think this through a little bit longer. But the short sellers are there.
Um They've got a lot of positives, but there are some negatives, John. As a matter of fact, when you look at where this stock is right now at under 400, this is a stock that was trading 745 at the 52-week highs. So, uh significantly off of that level. And I think part of it is the selling that we're we're looking at here. Some of the numbers that they put up, John, the Q4
results, though, were pretty spectacular. I mean, when you look at free cash flow, for instance, of 3.95 billion, uh I would say that's not so bad. So, there's some good and some bad going on with AppLovin, but uh right now, the bad is is holding up a little bit better because it's down
anywhere between 8 and 10% today.
Well, then we can go to another AI use of AI, Pete. This is in the corporate travel and expense side, T&E, as we like to call it. Um NAVN.
Um this one's up huge. So, uh it came public, folks, uh in October of 2025. And it was up north of 20 bucks a share. Well, until it uh uh saw this big comeback today, which is driving it up 25 or more percent, maybe
27%.
Um just a couple days ago, Pete, uh this one last week was $8.50.
Yeah. So, from over 20 to $8.50 is pretty much an ugly drop. But you uh perhaps caught some of those shorts that Jeff just talked about. You might have caught some of those shorts in the area where they need to cover
fast, and they're chasing shares higher.
Yep. The squeeze, as they say, right?
And that that's I think what we're looking at right here. You talked about it being about a 25% move to the upside.
This thing is a heck of a lot closer, John, to the 52-week lows than they are the highs. The 52-week low was eight, the high was 23, and it's trading just around that $11, maybe a little bit more than 11 bucks, but the numbers that they put up very solid, strong demand for what they what they're doing with the big enterprise customers and all the
rest. Um, so there's a lot that you could say is very positive, but um, including their forecast, which is why the stock is making this kind of a move, but um, it is a long ways, John, from that 20 and actually 23 level in terms of the 52-week high where it's trading now at 11. So, one that maybe gets
pretty interesting now, right? I mean, if things are going well and this thing's gotten beat up as much as it has, maybe it's making that turn. And I don't think that means you have to do something today. I think that's one of these where put that on your schedule to take a look at each and every day and decide um, that maybe they have turned the
corner and this thing can go up a little bit better.
Well, um, let's let's take a look at one Pete where people aren't betting on upside, at least not right now. Um, this is uh, WVE, which is known as Wave Life Sciences. They use ribonucleic acid or
RNA uh, medicines to basically try to transform um, how humans react to certain things. For instance, weight gain. So, think of them as a competitor, I guess, Pete, to Wegovy or to any of the semaglutides out there, um, because
that's exactly the space they were hoping to really uh, exploit.
Back in December, this is a $7 stock. It shot all the way up to 21 on what Pete always warns all of us about, which is, man, they they look like they had a pretty good trial.
Pretty good trial and the stock just exploded up to, you know, well north of 20 bucks a share from eight. So, it's the exact opposite of what we just talked about. Um, but then tragedy struck as as uh, Rosanne, Rosannadanna
would say, because did they come out with another great bit of uh, um, results from a test, Pete? Yes, they did. But, it wasn't nearly as big as what people were looking for. I mean, they're really
hoping if you're um, going to, you know, up-seed uh, you know, Novartis, NOV, uh, or any of these guys that have got a weight loss drug, you need to really blow it out of the water. They need to
see, okay, 30% drop in uh, in fat and so forth. Well, they had a good drop, but it wasn't nearly what the street had priced in with that jump to over 20. And that's why, Pete, it's trading down 57%.
Yeah, you're right on all the categories, John. The one thing, here's what stands out for me, though. Um, this is phase one, so it's very early still, right? And uh, some disappointment, right? I mean, so that that's part of the issue here. Um, and it's an obesity drug and people talk about that in the early stage, obviously, with phase one.
But, what what I'm curious about was, John, there I came away from it with some very positives, um, which is why I I would consider this stock. I like the balance sheet. I think it's pretty interesting. Stock's down, like you said, anywhere between 54, 57%, whatever. It's it's awful, right? I
mean, these guys are getting crushed.
But, the weight loss part was underwhelming. That's what people are are angry about right now in terms of why they're selling, right? They didn't really hit it on the weight loss.
But, how about this? I don't know if it's all about weight loss. It cuz I'm looking at it, John, and I saw that they had this they had improvements in body composition. They had a reduction in visceral fat. Um, and that was all after one dose. So, I'm looking at that going, well, you're
doing it for the health reasons for the most part. And, you know, obviously, the other benefit is losing weight. Well, if you're not losing weight and that's part of the issue that you've got, but on the other side of it, you're you're you're really getting a lot of things done that you're probably looking for. So, I don't
know. I look at this one as, hey, this might be an opportunity because uh, you know, I I obviously, weight loss is a big deal, a lot of competition out there, but I think that these guys, if they can figure out any way at all to improve that weight loss just even a fractional amount, they're they're they're targeting on the right things
right now, and that's what I do like about this one, John. I mean, if you and I went in there and they said, "Hey, look, your weight's not going to change a whole lot, but a lot of your fat's going to turn into muscle and this is going to happen to that and whatever." Um, I think that would be something that would be should be uh, what you're really looking for, quite honestly. I
mean, you could still weigh 200 lb, let's just as an example, but that 200 lb has shifted. And that's really what you're looking for in a lot of ways, right? And muscle weighs more than fat and all the rest of it. So, I don't know. I I'm not as concerned about the fact that the weight loss is is as big an issue as this is being made up.
Yep, you're right. It's the visceral fat. And that's why I think, Pete, I mean, it hit a new 52-week low today at $5.02.
So, I am right there with my brother, folks, thinking that this would be one that I like at this level. I'll certainly take a good, hard look at trying to throw on a call spread or something. Give myself a little time, Pete. Maybe give myself two or three months, but again, it was eight bucks in
December. It shot up through 20 and now it's, you know, below six. I think that represents potentially some really good stuff. And again, as Pete said, there's some people who really are not all that hot on taking that shot every week, Pete. You
know, pinching a little bit of fat and sticking that needle in there. Granted, it's a very thin needle, but nonetheless, um, there are people that don't like that. And that's why some people are developing pills and things like that. But, if you only have to have one dose to get 14% of your visceral fat
uh, burned off over the course of the next couple months, that doesn't sound so bad to me. Me, neither.
>> [laughter] >> All right, let's wind it up, Pete, with uh, um, Miller Knoll, uh, MLKN.
It's down over 20% today early on.
Shares plunged after they said, "You know what? Our Q3 results, we missed expectations, um, and revenue was also a miss. Orders did grow at just under 10%, Pete, so that's the good news, but uh, they
didn't have enough guidance forward to uh, reverse course on this big sell-off that we're seeing in MLKN.
Yeah. Yeah, it's a tough one for these guys. Interior furnishings is what they do and all the rest of it. But, when you look at the the Q3 earnings, John, they miss on the earnings, they miss on the revenue, that's not good. Uh, gross margins is down, not up, down 5.7%, that's not good. And then you give a soft outlook. This is exactly what a
stock looks like when when that's the delivery that you gave the public. And that's not so good. It's also a reason why this stock is hovering very close to those 52-week lows. So, um, at least for now, now you you mentioned the one positive thing and that's great, but unfortunately, I think the negatives
outweigh that right now, John, and they're going to have to prove that they can get this thing turned back around and get themselves moving in the right direction and start getting maybe the gross margins in positive territory and all the rest. So, uh, for now, this is one of those names where this one I would be saying, "You know what? Uh, no
reason, 52-week low, I get it, but I don't see a reason right now why I would be buying it." Back in July of '21, Pete, I think the stock was north of 50. And obviously, um, uh, it's having a big drop today um,
because, gosh, where'd she close yesterday? Let me see. Previous close was 1936.
Um, today's low, 1424.
And we're pretty much not much off those lows right now, so yeah, that's uh, I'm right there with you. I I think this is a different animal than uh, the one we just described with Wave, WVE. This one uh, selling, you know, uh, uh, furniture
and so forth. Um, I'm not willing to buy it just yet. No.
All right. Uh, we know again that you guys love these videos, so do we have more sports videos? You bet we do. Um, let's give you a little bit of uh, maybe a peek behind the curtain in the Bears war room, shall we, Pete?
>> Yeah.
Yeah. I love it. We're going to run a mock draft from ESPN's Field Yates in under 60 seconds. Share this video with all your Bears fans. Okay, Yates had Zion Young, the edge rusher out of Missouri, going to Chicago at 25 overall. 6'6", 262, power edge rusher who can set the edge in the run game and
had a 17% pass rush rush win rate. I think that's a Dennis Allen edge rusher that I like.
I love getting Jacob Razzano at 57 57 overall in the second round. I think he's a first-round player. I think he's better than C.J. Allen out of Georgia.
After Arvel Reece and Sunny Styles, he's my favorite linebacker in this draft.
You get him late round two, love that.
And then Tre'Vius Hodges-Tomlinson, the versatile freak athlete out of Arizona who played mostly nickel and safety. I think he could potentially play outside corner as well. I would trust Dennis Allen to find a spot for him in this secondary. Let me know what your favorite pick is and rate this mock draft.
I like the mock draft.
>> Yeah. Yeah, I Well, and I'll say this about about what's going on in Chicago, John. They've already turned the corner. I mean, they did such a great job last year free agency and drafting and everything and obviously the coach coming from Detroit, which hurt Detroit. And one of these days I think they'll get that that back, but I mean, when you lose your offensive
and defensive coordinator, it's understandable why Detroit wasn't the same team last year that they looked like they could be. Had both those coordinators been there, John? I think they would have been a Super Bowl type team. So, uh, you know, that's how high I I think of what what they've done up in Detroit, but now they've got to kind of reek work
that a little bit and I think the Bears with those players that he was talking about, I uh I think that that would really turn around. The tough thing is, we project that those guys are going to be there.
Uh, are they really going to be there when the time comes? That's that's the tough part. I mean, that's, you know, that that is always going to be the tough part. John, let's So, let's go to the NFL first and I got a Major League Baseball thing for you. But, uh since we were just talking about the Bears, I just for fun, I wanted to look at this, right? The 2027
draft. So, we haven't even gotten to this year's draft, I'm already going a year out there. But, here's what I found so curious cuz I was reading about something on on, you know, one of the ESPN apps and all this and I'm looking at it and started following it along and I'm like, well, what in the world is going on? The University of Texas.
So, here here's what I've got for you.
They got the 2027 draft coming out there and they've got Texas has These are the players that they feel are somewhere in the very high end of the draft this coming year for for for the NFL in 2027.
Wide receiver, Cam Coleman. Quarterback, Arch Manning. Offensive tackle, Brandon Baker. Offensive tackle, Goosby. Edge rusher, Simmons. Linebacker, Biles.
Tight end, Masonus. I mean, John, these guys are loaded for bear. And when I was going through this whole thing and I looked at them, you know, Alabama's got quite a few, you know, maybe Ohio State's got quite a few, you know they will because that's who they are. But, Texas outweigh they were better than
anybody in terms of projections of players and where they might go in the draft next year.
Unbelievable what they're building down there, John, but they got to win. They you know, it's one of those things, if you've got that much talent, you've got to find a way to be in that national title game. You know, you might not win it, but you got to you got to get to the national title game, I think, when you've got that kind of talent.
What do you think about this and I I think Ohio State would probably be number two right now in terms of the quality athletes that they've got, John, and they just always do it year after year after year. Notre Dame probably could be thrown in there a little bit.
Of course, Bama, Georgia. What do you What do you think of this Texas though?
I mean, they they're not missing too many positions where they people have them rated that high with these players.
It's unreal.
No, and you just described uh, you know, mainly offensive players. Yeah. Um, which is great because, you know, both college and pro are offensive uh, minded. Uh, they want scoring. Uh, and they're going to get it. Especially now with the pros going
one foot in bounds, Pete, instead of two. Yeah. Um, that's going to change some games, I think. But, uh yeah, uh Arch really needs to step up. He did late in the season or at least halfway through the season last year. Um, but uh, he can't start slow. Not with all
that talent. If they've got all that talent and he starts slow, uh, Sarkisian's going to have to put somebody else in there.
Because as highly rated as he is and as highly paid as he is, Pete, probably the highest paid player in all of college football, Arch Manning. Yeah. He's got to perform and he can't have an off game ever Yeah. at at the money he's getting right now as a college player. Yeah, it
is amazing. And I mean, there's a guy at the University of Minnesota, John, what he's an edge rusher, right? He had a really good year again last year.
Quality guy, big kid, strong, fast, long, all everything you want. He He probably would go somewhere close to the second or third round at least, at the very least. You know, and maybe even lower first round type body. But, here's the problem. He's making so damn much money over there on campus that he
doesn't want to go to the NFL. He's coming back for another year at the University of Minnesota. And I How do I blame him? I think the guy's somewhere, John, in the range of just under two.
And when I say that, it's got an M at the end of it. So, yeah, this guy's probably smart to be capitalizing on that right now because as we all know, that's why the NFL is great because they've got rookie contracts and then they got contracts.
And it's a little bit different some of those numbers in the first couple of years. John, Major League Baseball, you and I are two financial guys, we're talking about sports for all the right reasons. You were a linebacker for the Bears, I was a linebacker at a couple different places, but I'm looking at the Major League Baseball because it starts. And And here we go,
right? Well, here's what the numbers look like in Major League Baseball.
Dodgers, Ohtani, $127 million is what he's going to make. Tux, 56 million. The Yankees, Bellinger, 56 million. Judge, 46 million. Cole, 437 million. So, Joe at at the Mets,
uh, 52 million. I'm just going to write And then Betts yet, another 42 million.
The numbers are absolutely extraordinary in the NFL, the NHL, the WNBA even. I don't know if you saw Caitlin Clark's numbers, but holy crap. I mean, right?
Almost 10 extra. Almost 10 extra. Yeah, it's unbelievable.
>> to 500 and something thousand. I know it's not a full 10x, but um, you know, strong eight times her money.
Um, and obviously she does it for the contracts, for the sponsorships um, more than for the what they make playing.
I'm still surprised, Pete, uh, that the NBA is willing to lose money as much as it's willing to lose um, putting product on the floor with the WNBA, but they didn't ask me. They just think that it's uh, going to pay off down the line.
I've heard smart people say that those franchises have gone up substantially.
Yeah.
and I know they've gone up in soccer, men's and women's soccer, but I don't think uh, the WNBA can really justify what the NF what the NBA is playing is paying for right now. Right. Maybe it'll play out in the next few years, Pete. I don't know. It just depends, but it's
it's uh, not something I'd bet on right now.
Yeah. Well, and the the crazy thing, John, is Stephen A had a great take on this just yesterday as a matter of fact when it comes to Major League Baseball because he basically just said what you and I would say, which is these guys got no real cap, right? I mean, you know, so it's it's it's crazy the money that really flows in Major
League Baseball. The NFL, one of the things that makes them so great is there is a cap. Now, it slides up and we always know you kind of lean into it a little bit on the slide up or whatever cuz that's the expectation and they've been very right with that, but he was talking about How about this, John? The Dodgers have spent
30 million more than ever everybody else. They've sort of $30 million more.
Nobody's close. So, it's unbelievable what they've got going on and his frustration was, how can everybody compete? They're going out and they're getting the very best and they're paying the very best and they've got the team the right TV deals, which not everybody in Major League Baseball has the right kind of deals. The New York teams sure do and they're right in there, right?
You've got the Yankees and the Mets.
Those three are the top three. And so, it's just one of those things where LA is absolutely loaded and Stephen A was saying, hey, there might be a better way to do this and they might want to start thinking about that. You know, Stephen A's pretty darn smart guy. People might not like him or maybe they do. I love the guy. I
think he's great. I I think he's great, too. Yeah. Um Yeah, they don't share TV revenue, Pete.
Um, the only time they do is I think the Sunday night game and the World Series, the playoffs and the World Series. Other than that, like you said, the YES Network with the Yankees or the Dodgers with theirs, I mean, how do you compete if you're Cincinnati and you're a small market team like
Minnesota or Cincinnati? How do you compete? And quite frankly, the answer is you can't.
Not really. Um, you you can, you know, a game here and a game there you can win, but a best of seven, not happening. Not happening. Unless the other guy somehow had just a whole bunch injuries, um, you're not beating them best of seven.
Um, when you have uh, when you have a spend that's under 70 mil and they're spending 260 million, you're not beating them. Yeah, I don't No, and it it I think he's right. It hurts the sport to some degree, right? I mean, you know, you it sure makes it tougher on those the the smaller the
mini the Minnesotas of the world and the Cincinnatis and the and you know, many of these, but yeah, those big three, they've got money out the wazoo. We all know that. Well, that's all That's all we got for this week on the sports side of it as well, John.
All right. Well, thanks for joining us, folks.
Um, let us know what you thought of Jeff Garbaz and his short report because the the rebel short squeeze is a very popular item and Jeff certainly has added some new tweaks to it that are pretty special. So, we will be back next
Monday at 1:00 p.m. Eastern time. We hope you have a great day and trade them up today and tomorrow, folks. We'll see you next week.

Transcript from the show's YouTube captions; automatic captions may contain errors. Educational content, not investment advice.